<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7905589</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6173</journal-id>
<journal-id journal-id-type="nlm-ta">Neurotoxicology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurotoxicology</journal-id>
<journal-title-group>
<journal-title>Neurotoxicology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0161-813X</issn>
<issn pub-type="epub">1872-9711</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26439099</article-id>
<article-id pub-id-type="pmc">4753107</article-id>
<article-id pub-id-type="doi">10.1016/j.neuro.2015.10.001</article-id>
<article-id pub-id-type="manuscript">NIHMS738094</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Persistent behavioral effects following early life exposure to retinoic acid or valproic acid in zebrafish</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bailey</surname>
<given-names>Jordan M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oliveri</surname>
<given-names>Anthony N.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Karbhari</surname>
<given-names>Nishika</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brooks</surname>
<given-names>Roy A.J.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De La Rocha</surname>
<given-names>Amberlene J.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Janardhan</surname>
<given-names>Sheila</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Levin</surname>
<given-names>Edward D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA, 27710</aff>
<aff id="A2"><label>2</label>Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA, 27710</aff>
<author-notes>
<corresp id="FN1">Communicating author: Edward D. Levin, Ph.D., Department of Psychiatry and Behavioral Sciences, Box 104790, Duke University Medical Center, Durham, NC 27710, USA, <email>edlevin@duke.edu</email>, Phone: 1-919-681-6273; Fax: 1-919-681-3416</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2017</year>
</pub-date>
<volume>52</volume>
<fpage>23</fpage>
<lpage>33</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuro.2015.10.001-->
<abstract>
<sec id="S1">
<title>BACKGROUND</title>
<p id="P1">Moderate to severe dysregulation in retinoid signaling during early development is associated with a constellation of physical malformations and/or neural tube defects, including spina bifida. It is thought that more subtle dysregulation of this system, which might be achievable via dietary (i.e. hypervitaminosis A) or pharmacological (i.e. valproic acid) exposure in humans, will manifest on behavioral domains including sociability, without overt physical abnormalities.</p>
</sec>
<sec id="S2">
<title>METHODS</title>
<p id="P2">During early life, zebrafish were exposed to low doses of two chemicals that disrupt retinoid signaling. From 0-5 dpf, larvae were reared in aqueous solutions containing retinoic acid (0, 0.02, 0.2 or 2 nM) or valproic acid (0, 0.5, 5.0 or 50 uM). One cohort of zebrafish was assessed using a locomotor activity screen at 6-dpf; another was reared to adulthood and assessed using a neurobehavioral test battery (startle habituation, novel tank exploration, shoaling, and predator escape/avoidance).</p>
</sec>
<sec id="S3">
<title>RESULTS</title>
<p id="P3">There was no significant increase in the incidence of physical malformation among exposed fish compared to controls. Both retinoic acid and valproic acid exposures during development disrupted larval activity with persisting behavioral alterations later in life, primarily manifesting as decreased social affiliation.</p>
</sec>
<sec id="S4">
<title>CONCLUSIONS</title>
<p id="P4">Social behavior and some aspects of motor function were altered in exposed fish; the importance of examining emotional or psychological consequences of early life exposure to retinoid acting chemicals is discussed.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Zebrafish</kwd>
<kwd>retinoic acid</kwd>
<kwd>vitamin A valproic acid</kwd>
<kwd>behavior</kwd>
<kwd>cognition</kwd>
<kwd>social behavior</kwd>
<kwd>development</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>